Trials / Completed
CompletedNCT06992297
Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Malaria, endemic in 85 countries, remains a major concern. By 2022, there will be 249 million cases and 608,000 deaths, 94% of them in Africa. In France, 4995 cases of imported malaria were reported in 2021, with 15% of severe forms and a fatality rate of 2.5%. Long-term sequelae, such as kidney failure and neurological disorders, are well documented in children, but few studies have focused on adults. the main objective is to describe and estimate the frequency of long-term sequelae of severe imported malaria treated at our centre. the aim is to compare long-term neurological sequelae between neuromalaria and severe malaria without neurological disorders. In addition, the investigator aim to identify the clinical, radiological and biological factors associated with sequelae in order to improve post-hospitalisation follow-up. Finally, the investigator aim to describe acute complications arising at diagnosis and during hospitalisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | a standardised, structured questionnaire, validated by the department's clinicians, to assess the physical, cognitive and psychological after-effects. |
Timeline
- Start date
- 2025-06-17
- Primary completion
- 2025-09-13
- Completion
- 2025-09-13
- First posted
- 2025-05-28
- Last updated
- 2025-12-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06992297. Inclusion in this directory is not an endorsement.